PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
2993772-6	1985	Both extrinsic and intrinsic asthmatics had significantly enhanced 5-lipoxygenase activity, which was expressed as the sum of percentage conversion of 14C-arachidonic acid into 5-HETE and 5,12-diHETE.	14c-arachidonic acid	151-171	arachidonate 5-lipoxygenase	Homo sapiens	67-81
3923563-1	1985	5,8,11,14-eicosatetraynoic acid (ETYA), a widely used inhibitor of cyclooxygenase and lipoxygenase, inhibited the incorporation of 14C-arachidonic acid into cell lipids of the murine thymoma EL4 whereas oleic acid had no effect.	14c-arachidonic acid	131-151	epilepsy 4	Mus musculus	191-194
6431000-11	1984	Incorporation of 14C-arachidonic acid into 23A4 cells, followed by stimulation of the cells with GEF, resulted in the release of 14C-arachidonate.	14c-arachidonic acid	17-37	rho/rac guanine nucleotide exchange factor (GEF) 2	Mus musculus	97-100
6431565-1	1984	When human polymorphonuclear leukocytes (PMNL) were incubated with exogenous 14C-arachidonic acid only traces of 5-lipoxygenase products including 5-HETE and leukotriene B4 were detected.	14c-arachidonic acid	77-97	arachidonate 5-lipoxygenase	Homo sapiens	113-127
6421543-1	1984	In the present study we compared the synthesis of various cyclooxygenase products in albino rabbit, dog (puppy and adult), cat, cow and human ocular tissues from 14C-arachidonic acid (AA).	14c-arachidonic acid	162-182	prostaglandin-endoperoxide synthase 1	Canis lupus familiaris	58-72
6819604-7	1982	Endothelial cells released 14C-arachidonic acid as well as 14C-prostaglandins in response to either histamine or bradykinin.	14c-arachidonic acid	27-47	kininogen 1	Homo sapiens	113-123
7030066-3	1981	In paired experiments, in the presence of endotoxin, the addition of the aggregating agent thrombin (0.5 U/ml) caused human platelets to release 29.1 +/- 3.4% of 14C-arachidonic acid from prelabeled platelet phospholipids.	14c-arachidonic acid	162-182	coagulation factor II, thrombin	Homo sapiens	91-99
197570-4	1977	The influence of PGE1 with theophylline, and dibutyryl cyclic AMP on the thrombin induced release of 14C-arachidonic acid from platelet membrane phospholipids was also investigated.	14c-arachidonic acid	101-121	coagulation factor II, thrombin	Homo sapiens	73-81
9211348-6	1997	Compared to adults, neonates had a lower renal cortical cytosolic PLA2 (cPLA2) activity, assessed as the release of 14C-arachidonic acid (AA) from labeled phosphatidyl choline (0.44 +/- 0.10 vs. 0.74 +/- 0.06% 14C-AA released/min/mg protein, P < 0.05) and microsomal PLA2 activity (0.32 +/- 0.03 vs. 1.20 +/- 0.13% 14C-AA released/min/mg protein, P < 0.001).	14c-arachidonic acid	116-136	cytosolic phospholipase A2	Oryctolagus cuniculus	72-77
9211348-6	1997	Compared to adults, neonates had a lower renal cortical cytosolic PLA2 (cPLA2) activity, assessed as the release of 14C-arachidonic acid (AA) from labeled phosphatidyl choline (0.44 +/- 0.10 vs. 0.74 +/- 0.06% 14C-AA released/min/mg protein, P < 0.05) and microsomal PLA2 activity (0.32 +/- 0.03 vs. 1.20 +/- 0.13% 14C-AA released/min/mg protein, P < 0.001).	14c-arachidonic acid	116-136	phospholipase A2	Oryctolagus cuniculus	66-70
8106748-7	1994	Finally, UVA exposure almost completely abolished the EGF-induced increase in diacylglycerol production from 14C-arachidonic acid-labeled lipids in both cell types.	14c-arachidonic acid	109-129	epidermal growth factor	Homo sapiens	54-57
2968795-3	1988	The activity of cellular phospholipase A2 was considered as the release of free 14C-Arachidonic acid in the cell supernatant.	14c-arachidonic acid	80-100	phospholipase A2, group IB, pancreas	Mus musculus	25-41
3203637-6	1988	PLA2 was measured by the liberation of 14C-arachidonic acid from 1-stearoyl-2-[1-14C]arachidonyl-L-3-phosphatidylcholine.	14c-arachidonic acid	39-59	phospholipase A2 group IB	Homo sapiens	0-4
2836681-2	1988	The reaction was dependent on lipoxygenation, was potentiated by indomethacin (IM) and was inhibited by nordihidro-guairetic acid (NDGA), (iii) both 14C-arachidonic acid (14C-AA) release and leukotriene B4 (LTB4) synthesis of ME-treated PMNLs were elevated as compared to those of FMLP triggered cells.	14c-arachidonic acid	149-169	formyl peptide receptor 1	Homo sapiens	281-285
3131780-1	1988	In an attempt to elucidate the possible involvements of eicosanoids in esophageal functions and disorders, we have investigated the formation of both cyclooxygenase and lipoxygenase metabolites from 14C-arachidonic acid by rabbit esophageal tissues.	14c-arachidonic acid	199-219	polyunsaturated fatty acid lipoxygenase ALOX15	Oryctolagus cuniculus	169-181
3131780-9	1988	The present findings indicate that rabbit esophageal tissues can convert 14C-arachidonic acid into lipoxygenase as well cyclo-oxygenase products which may have a role in esophageal physiology and pathophysiology.	14c-arachidonic acid	73-93	polyunsaturated fatty acid lipoxygenase ALOX15	Oryctolagus cuniculus	99-111
3124291-2	1987	Bovine coronary endothelial cells converted 14C-arachidonic acid to radioactive 6-keto PGF1 alpha (the stable metabolite of PGI2) and to a lesser extent PGE2.	14c-arachidonic acid	44-64	prostaglandin F synthase 2	Bos taurus	87-91
2444995-2	1987	Bradykinin, histamine, and phosphatidic acid were found to liberate 14C-arachidonic acid from membrane phospholipids, whereas leukotrienes B4 and C4 were ineffective in this respect.	14c-arachidonic acid	68-88	kininogen 1	Homo sapiens	0-10
3936117-2	1985	Here the presence of 5-lipoxygenase activity in the whole ovary and in the Graafian follicle is estimated by a chemiluminescence assay using unlabeled arachidonic acid as substrate in the presence of luminol and by conversion of 14C-arachidonic acid into lipoxygenase products as separated by HPLC.	14c-arachidonic acid	229-249	arachidonate 5-lipoxygenase	Rattus norvegicus	21-35